Detalles de la búsqueda
1.
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.
Eur J Haematol
; 104(3): 162-169, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31724208
2.
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens.
Blood
; 117(6): 1799-805, 2011 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-21148082
3.
Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.
Blood
; 115(25): 5137-46, 2010 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-20393132
4.
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.
Haematologica
; 96(10): 1470-7, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21685470
5.
Real life outcomes of patients aged ≥75 years old with acute promyelocytic leukemia: experience of the PETHEMA registry.
Leuk Lymphoma
; 60(11): 2720-2732, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31068052
6.
An analysis of the impact of CD56 expression in de novo acute promyelocytic leukemia patients treated with upfront all-trans retinoic acid and anthracycline-based regimens.
Leuk Lymphoma
; 60(4): 1030-1035, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30322324
7.
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapy.
Leuk Lymphoma
; 60(5): 1146-1155, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30526152
Resultados
1 -
7
de 7
1
Próxima >
>>